Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin Versus Metformin in PCOS
NCT07810998Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Sep 2026
- Primary completion
- Apr 2027
01
Overview
A Phase 3 trial of dapagliflozin in polycystic ovary syndrome (PCOS), sponsored by Tanta University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07810998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810998.